Search - tctmd.com

Displaying 261 - 280 of 709

Sort: Relevancy | Date

Presentation TCT 2023

TCT 172: National Readmission Data Based Analysis of Comorbidities and Mortality With Sex Specific Mortality of Transcutaneous vs Open Surgical Tricuspid Valve Interventions

Presenter: Abdul Baqi

October 25, 2023

Presentation TCT 2023

TCT 646: Percutaneous Tricuspid Valve-in-Valve Implantation in Failed Surgical Bioprosthetic Valves - Brazilian Single Center Registry

Presenter: Filippe Filippini

October 25, 2023

Presentation TCT 2023

TCT 373: Evaluation of the New Version of the MonarQ Transcatheter Tricuspid Bioprosthesis in a Large Animal Model

Presenter: Arshad Quadri

October 25, 2023

Presentation TCT 2023

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Presenter: Aneeza Jamshed

October 25, 2023

Presentation TCT 2023

TCT 318: First in Human Tricuspid Valve Replacement Compassionate Use Experience with a Novel Transcatheter Heart Valve Replacement System

Presenter: Jörg Hausleiter

October 25, 2023

Presentation TCT 2023

TCT 304: Cardiac Remodeling After Transcatheter Mitral Valve-In-Valve Intervention

Presenter: Cathevine Yang

October 25, 2023

Presentation TCT 2023

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

Presenter: edoardo zancanaro

October 25, 2023

Presentation TCT 2023

TCT 246: Nationally Representative Outcomes of Redo Surgical and Transcatheter Mitral Valve Replacement in Failed Mitral Bioprostheses

Presenter: Hiroki Ueyama

October 25, 2023

Presentation TCT 2023

TCT 171: National Estimates for Percentage of All Readmissions With Demographic Features, Length of Stay and Cost Analysis of Transcutaneous vs Open Surgical Tricuspid Valve Interventions

Presenter: Muhammad Khan

October 25, 2023

Presentation TCT 2023

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Presenter: Nir Uriel

October 25, 2023

Presentation TCT 2023

TCT 164: TRILUMINATE eligibility criteria in real-world patients receiving tricuspid valve transcatheter edge-to-edge repair

Presenter: Lukas Stolz

October 25, 2023

Presentation TCT 2023

TCT 101: Temporal trends in right ventricular to pulmonary artery coupling in patients undergoing transcatheter mitral valve-in-valve replacement for degenerated mitral bioprostheses

Presenter: Chen Chen

October 25, 2023

Presentation TCT 2023

PROs are a Powerful Endpoint in TR Interventional Trials

Presenter: Suzanne Arnold

October 25, 2023

Presentation TCT 2023

Second Wave Technology Will Solve Most Problems – TMVR is Here to Stay in a Big Way!

Presenter: Juan Granada

October 25, 2023

Presentation TCT 2023

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

TCT 481: Improvement of Tricuspid Regurgitation by Interventional Annuloplasty - One-Year Outcomes of a Single-Center Registry

Presenter: Stephan Haussig

October 25, 2023

Presentation TCT 2023

TCT 72: Improvement in Echocardiographic Mitral Regurgitation Parameters Correlates With LV Reverse Remodelling in Patients Undergoing Percutaneous Mitral Annuloplasty With the Carillon Technique

Presenter: Tomasz Siminiak

October 25, 2023

Presentation TCT 2023

Con: Rebuttal

Presenter: Sam Dawkins

October 25, 2023

Presentation TCT 2023

TCT 71: The Outcomes of Percutaneous Mitral Annuloplasty With the Carillon Device: Retrospective Analysis of Implanted vs Non-implanted Patients

Presenter: Tomasz Siminiak

October 25, 2023

Presentation TCT 2023

Con: Earlier is Better - It Will Save Lives if We Do it Right?

Presenter: Sam Dawkins

October 25, 2023

Advertisement

TCT 172: National Readmission Data Based Analysis of Comorbidities and Mortality With Sex Specific Mortality of Transcutaneous vs Open Surgical Tricuspid Valve Interventions

TCT 646: Percutaneous Tricuspid Valve-in-Valve Implantation in Failed Surgical Bioprosthetic Valves - Brazilian Single Center Registry

TCT 373: Evaluation of the New Version of the MonarQ Transcatheter Tricuspid Bioprosthesis in a Large Animal Model

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

TCT 318: First in Human Tricuspid Valve Replacement Compassionate Use Experience with a Novel Transcatheter Heart Valve Replacement System

TCT 304: Cardiac Remodeling After Transcatheter Mitral Valve-In-Valve Intervention

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

TCT 246: Nationally Representative Outcomes of Redo Surgical and Transcatheter Mitral Valve Replacement in Failed Mitral Bioprostheses

TCT 171: National Estimates for Percentage of All Readmissions With Demographic Features, Length of Stay and Cost Analysis of Transcutaneous vs Open Surgical Tricuspid Valve Interventions

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

TCT 164: TRILUMINATE eligibility criteria in real-world patients receiving tricuspid valve transcatheter edge-to-edge repair

TCT 101: Temporal trends in right ventricular to pulmonary artery coupling in patients undergoing transcatheter mitral valve-in-valve replacement for degenerated mitral bioprostheses

PROs are a Powerful Endpoint in TR Interventional Trials

Second Wave Technology Will Solve Most Problems – TMVR is Here to Stay in a Big Way!

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

TCT 481: Improvement of Tricuspid Regurgitation by Interventional Annuloplasty - One-Year Outcomes of a Single-Center Registry

TCT 72: Improvement in Echocardiographic Mitral Regurgitation Parameters Correlates With LV Reverse Remodelling in Patients Undergoing Percutaneous Mitral Annuloplasty With the Carillon Technique

Con: Rebuttal

TCT 71: The Outcomes of Percutaneous Mitral Annuloplasty With the Carillon Device: Retrospective Analysis of Implanted vs Non-implanted Patients

Con: Earlier is Better - It Will Save Lives if We Do it Right?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content